SNRPE, an Oncofetal Protein: can be a Diagnostic Marker and Therapeutic Target for Oral Cancers?
作者信息
Sanjay Somasundaram, Sharmila Muthusethupathi, Ezhilarasan Devaraj
机构信息
Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), No.162, PH Road, Chennai, 600 077, Tamil Nadu, India.
出版信息
Head Neck Pathol. 2024 Oct 15;18(1):99. doi: 10.1007/s12105-024-01709-3.
Abstract
摘要
相似文献
1
SNRPE, an Oncofetal Protein: can be a Diagnostic Marker and Therapeutic Target for Oral Cancers?
Head Neck Pathol. 2024 Oct 15;18(1):99. doi: 10.1007/s12105-024-01709-3.
2
Diagnostic Biomarkers in Oral Verrucous Carcinoma: A Systematic Review.
Pathol Oncol Res. 2017 Jan;23(1):19-32. doi: 10.1007/s12253-016-0150-x. Epub 2016 Dec 6.
3
Unravelling the Significance of NLRP3 and IL-β1 in Oral Squamous Cell Carcinoma and Potentially Malignant Oral Disorders: A Diagnostic and Prognostic Exploration.
Head Neck Pathol. 2024 Aug 14;18(1):77. doi: 10.1007/s12105-024-01685-8.
4
Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: a systematic review.
Acta Odontol Scand. 2016;74(3):170-7. doi: 10.3109/00016357.2015.1110249. Epub 2015 Nov 18.
5
Comparison of Manual Versus QuPath Software-based Immunohistochemical Scoring Using Oral Squamous Cell Carcinoma as a Model.
J Histochem Cytochem. 2025 May 15:221554251335698. doi: 10.1369/00221554251335698.
6
Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer.
Biomed J. 2024 Feb;47(1):100594. doi: 10.1016/j.bj.2023.04.002. Epub 2023 Apr 10.
7
Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing.
Br J Cancer. 2024 Jul;131(1):77-89. doi: 10.1038/s41416-024-02689-5. Epub 2024 May 25.
8
The relationship between salivary cytokines and oral cancer and their diagnostic capability for oral cancer: a systematic review and network meta-analysis.
BMC Oral Health. 2024 Sep 5;24(1):1044. doi: 10.1186/s12903-024-04840-3.
9
Prognostic Utility of Autophagy Marker Beclin1 in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Head Neck Pathol. 2025 Feb 5;19(1):17. doi: 10.1007/s12105-025-01755-5.
10
Opportunities for biomarkers with potential clinical use in oral cancer.
Medwave. 2015 Jul 20;15(6):e6186. doi: 10.5867/medwave.2015.06.6186.
本文引用的文献
1
Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing.
Br J Cancer. 2024 Jul;131(1):77-89. doi: 10.1038/s41416-024-02689-5. Epub 2024 May 25.
2
Molecular Insights into Oral Malignancy.
Indian J Surg Oncol. 2022 Jun;13(2):267-280. doi: 10.1007/s13193-021-01431-4. Epub 2021 Sep 11.
3
Novel fibroblast growth factor receptor inhibitors: Potential therapeutic approach in oral cancer treatment.
Oral Oncol. 2022 Sep;132:105983. doi: 10.1016/j.oraloncology.2022.105983. Epub 2022 Jun 23.
4
Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance.
Front Oral Health. 2021 Jan 25;1:603160. doi: 10.3389/froh.2020.603160. eCollection 2020.
5
SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26.
Cell Death Dis. 2019 Sep 11;10(9):667. doi: 10.1038/s41419-019-1929-y.
6
Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins.
Clin Cancer Res. 2017 Jan 15;23(2):336-341. doi: 10.1158/1078-0432.CCR-16-0131. Epub 2016 Nov 10.
7
FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma.
Pathobiology. 2015;82(6):280-9. doi: 10.1159/000439536. Epub 2015 Nov 10.
8
Roles of fibroblast growth factor receptors in carcinogenesis.
Mol Cancer Res. 2010 Nov;8(11):1439-52. doi: 10.1158/1541-7786.MCR-10-0168. Epub 2010 Oct 13.
9
Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis.
Oncologist. 2010;15(9):994-1001. doi: 10.1634/theoncologist.2009-0289. Epub 2010 Aug 26.
10
Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management.
Oral Oncol. 2009 Apr-May;45(4-5):317-23. doi: 10.1016/j.oraloncology.2008.05.016. Epub 2008 Jul 31.
Zotero 插件